Hostname: page-component-78c5997874-g7gxr Total loading time: 0 Render date: 2024-11-16T15:28:30.315Z Has data issue: false hasContentIssue false
  • English
  • Français

An Attempt to Produce Cholinergic Hypofunction in Rat Brain using Choline Mustard Aziridinium Ion: Neurochemical and Histological Parameters

Published online by Cambridge University Press:  18 September 2015

E.H. Colhoun ,
L.A. Myles  and
R.J. Rylett
E.H. Colhoun*
Affiliation:
Departments of Pharmacology/Toxicology, The University of Western Ontario, London
L.A. Myles
Affiliation:
Departments of Pharmacology/Toxicology, The University of Western Ontario, London
R.J. Rylett
Affiliation:
Department of Physiology, The University of Western Ontario, London
*
Department of Pharmacology & Toxicology, Health Sciences, The University of Western Ontario, London, Ontario, Canada N6A 5C1
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Deficiencies in cholinergic nerve function have been clearly documented in patients with Alzheimer's disease. The lack of this neurotransmitter may be responsible for early memory loss in patients with the disease. Choline mustard Az ion has been used in our laboratory to produce cholinergic hypofunction in rat brain. Injections of the compound into the medial septal nucleus and dorsal hippocampus produced tissue lesions. The lesions were dose and time-dependent. Lesions produced in the medial septum resulted in transmitter depression in the hippocampus. These results suggest non-specific tissue damage because 5-HT levels were lower than normal. Other strategies for getting choline mustard Az ion into rat brain are being investigated to circumvent the apparent ability of this compound and other nitrogen mustard analogs of choline to produce non-specific tissue damage when injected directly into brain tissue.

Type
Biochemical Studies
Information
Canadian Journal of Neurological Sciences , Volume 13 , Issue S4 , November 1986 , pp. 517 - 520
Copyright
Copyright © Canadian Neurological Sciences Federation 1986

References

1.Bartus, RT, Dean, RL, Beer, B, et al. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982; 217: 408–417.CrossRefGoogle ScholarPubMed
2.Bowen, DM, Benton, JS, Spillane, JA, et al. Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients. J Neurol Sci 1982; 57: 191–202.CrossRefGoogle ScholarPubMed
3.Sims, NR, Bowen, DM, Allen, SJ, et al. Presynaptic cholinergic dysfunction in patients with dementia. J Neurochem 1983; 40: 503–509.CrossRefGoogle ScholarPubMed
4.Fisher, A, Hanin, I.Potential animal models for senile dementia of Alzheimer’s type, with emphasis on AF64A-induced cholino-toxicity. Ann Rev Pharmacol Toxicol 1986; 26: 161–181.CrossRefGoogle Scholar
5.Asante, JW, Cross, AJ, Deakin, SF, et al. Evaluation of AF64A as a specific neurotoxin of brain cholinergic neurons. Brit J Pharmacol 1983; 80: 575p.Google Scholar
6.Levy, A, Kant, GJ, Myerhoff, JL, et al. Non-cholinergic neurotoxic effects of AF64A in the substantia nigra. Brain Research 1984; 305: 169–172.CrossRefGoogle ScholarPubMed
7.Rylett, RJ, Colhoun, EH.Interactions of choline mustard aziridinium ion with choline acetyltransferase. J Neurochem 1979; 32: 553–558.CrossRefGoogle ScholarPubMed
8.Rylett, RJ, Colhoun, EH. Kinetic data on the inhibition of high affinity choline transport into rat forebrain synaptosomes by choline-like compounds and nitrogen mustard analogues. J Neurochem 1980; 34: 713–719.CrossRefGoogle ScholarPubMed
9.Rylett, RJ, Colhoun, EH.An evaluation of irreversible inhibition of synaptosomal high-affinity choline transport by choline mustard aziridinium ion. J Neurochem 1984; 43: 787–794.CrossRefGoogle ScholarPubMed
10. Paxinos, G, Watson, C.The rat brain in stereotaxic coordinates. New York, Academic Press, 1982.Google Scholar
11.Golumbic, C, Fruton, JS, Bergmann, M.Chemical reactions of the nitrogen mustard gases. J Org Chem 1946; 11:518–535.CrossRefGoogle ScholarPubMed
12.Kuhar, MJ, Zarbin, MA.Synaptosomal transport: a chloride depen- dence for choline, GABA, glycine and several other compounds. J Neurochem 1978; 31: 251–256.CrossRefGoogle Scholar
13.Fonnum, F.Isolation of choline esters from aqueous solutions by extraction with sodium tetraphenylboron in organic solvents. Biochem J 1969; 113: 291–298.CrossRefGoogle ScholarPubMed
14.Ellman, GL, Courtney, KD, Andres, V, et al. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7: 88–95.CrossRefGoogle ScholarPubMed
15.Chalmers, A, McGeer, EG, Wickson, H, et al. Distribution of glutamic acid decarboxylase in the brains of various mammalian species. Comp Gen Pharmac 1970; 1: 385–390.CrossRefGoogle ScholarPubMed
16.Fibiger, HC. The organization and some projections of cholinergic neurons of the mammalian forebrain. Brain Res Rev 1982; 4: 327–388.CrossRefGoogle Scholar
17.Spencer, DG, Horvath, E, Luitten, P, et al. Novel approaches in the study of brain acetylcholine function: neuropharmacology, neuroanatomy, and behaviour. Traber, J, Grispen, SH, eds. Senile Dementia of the Alzheimer Type. Berlin, Springer-Verlag, 1985; 325–342.Google Scholar
18.Swertka, SA, Olson, GL.Neuropathology and amphetamine-induced turning resulting from AF64A injections into the striatum of the rat. Life Sci 1986; 38: 1105–1110.CrossRefGoogle Scholar
19.Morgan, IG, Ishimoto, I, Boelen, M.Selective destruction of the cholinergic amacrine cells of chicken retina with AF64A. Invest Opthalmol vis Sci 1984; 25: suppl. 104.Google Scholar